Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alex azar
alliance for aging research
amgen
biogen
biotechnology innovation organization
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drug pricing
duane schulthess
1
×
eli lilly
erica whittaker
fda
indiana blog main
indiana top stories
jim greenwood
life sciences
medicaid
medicare
nancy pelosi
natalizumab
1
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
regeneron pharmaceuticals
san diego blog main
san diego top stories
san francisco blog main
1
×
san francisco top stories
seattle blog main
seattle top stories
susan peschin
texas blog main
What
administration
angry
anti
benefited
despite
drug
1
×
fear
industry
losing
pharma
plans
presidential
price
rhetoric
rx
scalps
split
thanks
trump
tweets
Language
Current search:
natalizumab
×
" duane schulthess "
×
drug
×
" san francisco blog main "
×
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans